Pfizer wants a slice of the weight-loss pie
The drugmaker announces plans to start clinical trials of a formulation that will give it a shot at a space dominated by Eli Lilly and Novo Nordisk’s blockbuster offerings.
11 July, 2024•2 min
0
11 July, 2024•2 min
0
More in Business
Business
NSE moves to settle colocation case with SEBI, sees sharp dip in profit
The stock exchange’s Q2 bottom line slipped on the back of a near Rs 1,300 crore provision to settle the long-pending case.
You may also like
Business
Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
